Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:12 AM
Ignite Modification Date:
2025-12-25 @ 1:12 AM
NCT ID:
NCT02192593
Eligibility Criteria:
Inclusion Criteria:
* Participants will be on a stable dose of antipsychotic medication for the past 3 months.
* Schizophrenia-spectrum diagnosis, including schizophrenia, schizoaffective disorder, schizophreniform disorder, and psychosis, not otherwise specified.
* At least moderate severity on Brief Psychiatric Rating Scale (BPRS) hallucinations item.
* Naïve to CBTp for Auditory Hallucinations within the past 3 years.
* No current suicidal ideation or hospitalization within the past month.
* Reading level of at least 4th grade, as measured by the reading section of the Wide Range Achievement Test (WRAT)
* Current patient receiving care at Cambridge Health Alliance
Exclusion Criteria:
* Terminal physical illness expected to result in the death of the study participant within one year.
* Primary diagnosis of dementia or a diagnosis of a psychiatric disorder secondary to a medical condition.
* Comorbid dementia (severe cognitive impairment) as indicated by a Mini-mental state examination score \<24.
* Current active substance abuse or dependence with the need for specialized substance abuse services
* Does not speak English
* Does not achieve a 4th grade reading level as demonstrated on the Wide Range Achievement Test (WRAT)
* Has a legal guardian
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02192593
Study Brief:
Protocol Section:
NCT02192593